Testing effectiveness (Phase 2)Ended earlyNCT02587598What this trial is testingStudy of INCB053914 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 97
Early research (Phase 1)Study completedNCT03386526What this trial is testingAPG-1387 in Patients With Advanced Solid Tumors or Hematologic MalignanciesWho this might be right forAdvanced Solid Tumors or Hematologic Malignancies Ascentage Pharma Group Inc. 90
Large-scale testing (Phase 3)Study completedNCT00230178What this trial is testingRasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeWho this might be right forTumor Lysis SyndromeCancerHyperuricemia Sanofi 280
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Study completedNCT00002621What this trial is testingInterferon Alfa in Treating Children With HIV-Related CancerWho this might be right forLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 8
Testing effectiveness (Phase 2)Study completedNCT01422499What this trial is testingVorinostat in ChildrenWho this might be right forChildren With Relapsed Solid Tumor, Lymphoma or Leukemia National Center for Tumor Diseases, Heidelberg 50
Not applicableStudy completedNCT05790538What this trial is testingPredicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )Who this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm OHSU Knight Cancer Institute 200
Early research (Phase 1)Study completedNCT04944888What this trial is testingGSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid TumorWho this might be right forSolid TumorHematologic Malignancy Chinese PLA General Hospital 31
Not applicableUnknownNCT04743388What this trial is testingStudy of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune SystemWho this might be right forCOVID-19Healthy VolunteersChronic Disease+2 more National and Kapodistrian University of Athens 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Not applicableAvailableNCT05974410What this trial is testingExpanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsWho this might be right forGlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more AVM Biotechnology Inc
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01421524What this trial is testingStudy of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple MyelomaWho this might be right forMultiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more Celgene 271
Early research (Phase 1)Ended earlyNCT03783403What this trial is testingCC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic CancersWho this might be right forNeoplasms Celgene 206
Not applicableStudy completedNCT00920738What this trial is testingMetabolic Syndrome in Childhood Cancer SurvivorsWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+2 more University of Minnesota 512
Not applicableLooking for participantsNCT02402244What this trial is testingProject: Every Child for Younger Patients With CancerWho this might be right forAdrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more Children's Oncology Group 75,000
Early research (Phase 1)Ended earlyNCT04214093What this trial is testingAZD0466 in Patients With Advanced Hematologic or Solid TumorsWho this might be right forAdvanced Solid TumorsLymphomaMultiple Myeloma+1 more AstraZeneca 9
Early research (Phase 1)Study completedNCT05237206What this trial is testingStudy of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic MalignanciesWho this might be right forOncology Alloplex Biotherapeutics Inc 46
Not applicableUnknownNCT02213822What this trial is testingMolecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic AnalysisWho this might be right forSolid TumorsHematological Malignancies Rhode Island Hospital 500